Return Home

IA2030 Scorecard — 

Global View

Impact Goal 3: Build strong immunization programmes
3.1

Deliver across the life course

What Does this Indicator Measure?

This indicator shows the proportion of targeted population that received the relevant vaccine and dose in that year for DTP (diphtheria-tetanus-pertussis), measles, pneumococcal disease, and HPV.

How Will Progress be Measured?

Globally, the IA2030 target is 90% for coverage of these four vaccines. Using the WHO and UNICEF estimates of national immunization coverage (WUENIC), the indicator will be evaluated annually at the global and regional level.

Vaccination coverage across the life course—Global

FIRST YEARDTP3
FIRST YEARPCV3
SECOND YEARMCV2
ADOLESCENTSHPVc

Summary Table

Vaccine20192020
DTP386%83%
PCV349%49%
MCV271%70%
HPVc14%12%
Definition: Immunization coverage for DTPcv-3, MCV-2, PCV3, and HPVc.
Measurement approach: Immunization coverage for a certain year is defined as the proportion of the targeted population that received the relevant vaccine and dose in that year. Measurement will be determined at the regional and global levels, using WHO and UNICEF estimates of national immunization coverage (WUENIC). Note that for WUENIC, the annually targeted population for globally recommended vaccines comprises the entire global cohort of surviving infants, regardless of whether the vaccine was introduced in their country.
Calculation: Denominator is the estimated population of the target group of children that should receive DTPcv-3, MCV-2, PCV3, and HPVc. The numerator consists of the target population who have received DTPcv-3, MCV-2, PCV3, and HPVc. The target population of children and their appropriate age for receiving the last vaccine dose is determined by national immunization schedules.